Literature DB >> 30116419

Infected Abdominal Aortic Aneurysm Caused by Campylobacter Jejuni.

Yohsuke Yanase1, Akihito Ohkawa1, Satomi Inoue1, Yukihiro Niida2.   

Abstract

A 69-year-old man presented with abdominal pain. Enhanced computed tomography (ECT) showed abdominal aortic aneurysm (AAA) with vessel wall thickening. Follow-up ECT on day 3 of admission showed expansion of the AAA. Endovascular abdominal aortic repair (EVAR) was urgently performed. Since preoperative blood cultures revealed Campylobacter jejuni infection, the antibiotics imipenem/cilastatin were administered for five weeks, followed orally by Clarithromycin. The patient was discharged on postoperative day 45. There was no recurrence of the aneurysm at 9 months after EVAR. To the best of our knowledge, this is the first report of EVAR for infected AAA caused by Campylobacter jejuni.

Entities:  

Keywords:  abdominal aortic aneurysm; infected aneurysm; stent graft

Year:  2018        PMID: 30116419      PMCID: PMC6094032          DOI: 10.3400/avd.cr.17-00135

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  10 in total

1.  Guidelines for diagnosis and treatment of aortic aneurysm and aortic dissection (JCS 2011): digest version.

Authors: 
Journal:  Circ J       Date:  2013-02-13       Impact factor: 2.993

Review 2.  Aortoiliac aneurysms infected by Campylobacter fetus.

Authors:  Frédéric Cochennec; Laure Gazaigne; Philippe Lesprit; Pascal Desgranges; Eric Allaire; Jean-Pierre Becquemin
Journal:  J Vasc Surg       Date:  2008-08-09       Impact factor: 4.268

Review 3.  Infected abdominal aortic aneurysm caused by Campylobacter fetus subspecies fetus: report of a case.

Authors:  S Mii; K Tanaka; K Furugaki; H Sakata; H Katoh; A Mori
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 4.  Mycotic abdominal aortic aneurysm caused by Campylobacter fetus: a case report and literature review.

Authors:  Hideharu Hagiya; Mitsuaki Matsumoto; Hiroshi Furukawa; Tomoko Murase; Fumio Otsuka
Journal:  Ann Vasc Surg       Date:  2014-07-11       Impact factor: 1.466

5.  Mycotic abdominal aneurysm caused by campylobacter fetus: a case report for surgical management.

Authors:  Yukihiro Noda; Ko-Ichiro Sawada; Syu-Hei Yoshida; Satoru Nishida; Shinichiro Yamamoto; Yuji Otake; Go Watanabe
Journal:  Ann Vasc Dis       Date:  2011-03-26

Review 6.  Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review.

Authors:  Chung-Dann Kan; Hsin-Ling Lee; Yu-Jen Yang
Journal:  J Vasc Surg       Date:  2007-10-01       Impact factor: 4.268

7.  Extra-anatomic revascularization and aortic exclusion for mycotic aneurysms of the infrarenal aorta and iliac arteries in an Asian population.

Authors:  Colin Y L Woon; Mathew G Sebastian; Kiang-Hiong Tay; Seck-Guan Tan
Journal:  Am J Surg       Date:  2008-01       Impact factor: 2.565

8.  Abdominal septic aortic pseudoaneurysm caused by Campylobacter jejuni infection: report of a case.

Authors:  Jun-Neng Roan; Wen-Chien Ko; Chwan-Yau Luo
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

9.  Endovascular treatment of mycotic aortic aneurysms: a European multicenter study.

Authors:  Karl Sörelius; Kevin Mani; Martin Björck; Petr Sedivy; Carl-Magnus Wahlgren; Peter Taylor; Rachel E Clough; Oliver Lyons; Matt Thompson; Jack Brownrigg; Krassi Ivancev; Meryl Davis; Michael P Jenkins; Usman Jaffer; Matt Bown; Zoran Rancic; Dieter Mayer; Jan Brunkwall; Michael Gawenda; Tilo Kölbel; Elixène Jean-Baptiste; Frans Moll; Paul Berger; Christos D Liapis; Konstantinos G Moulakakis; Marcus Langenskiöld; Håkan Roos; Thomas Larzon; Artai Pirouzram; Anders Wanhainen
Journal:  Circulation       Date:  2014-11-05       Impact factor: 29.690

10.  A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility.

Authors:  Benjamin Feodoroff; Anneli Lauhio; Patrik Ellström; Hilpi Rautelin
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.